Skip to main content
Premium Trial:

Request an Annual Quote

China's Science

The Washington Post tells the story of BGI's Zhao Bowen, a 17 year-old who began there as a summer intern working on the cucumber genome and now is delving into the genetics of intelligence. More generally, the Post article looks into China's rise in the sciences in general, and in genomics specifically and says that while some Chinese scientists are making tremendous advances, the field is plagued by scams and ethical concerns. Still, many US-educated Chinese researchers are returning to China. "If I had stayed in America, the chances of making a discovery would have been lower," says neurobiologist Luo Minmin, who is studying a gene associated with attention-deficit disorder. "Here, people are willing to take risks. They give you money, and essentially you can do whatever you want."

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.